Markets:

Overview

News

Currencies

International

Treasuries

Neumora Therapeutics, Inc. - Common Stock (NQ:NMRA)

2.111 -0.179 (-7.82%)

Streaming Delayed Price Updated: 10:01 AM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Neumora Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >

Top movers in Tuesday's pre-market session ↗

December 23, 2025

As the US market prepares to open on Tuesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Unusual volume stocks in Thursday's session ↗

October 30, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.

Via Chartmill

Unusual volume stocks in Wednesday's session ↗

October 29, 2025

In today's session, these stocks are experiencing unusual volume.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 27, 2025

Via Benzinga

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Earnings Scheduled For May 12, 2025 ↗

May 12, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Neumora Therapeutics’ Experimental Drug Demonstrates Weight Loss in Preclinical Studies ↗

October 27, 2025

Neumora said that NMRA-215 demonstrated weight loss of up to 19% as a monotherapy and 26% in combination with Semaglutide.

Via Stocktwits

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 23, 2025

Via Benzinga

This Warner Bros. Discovery Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗

September 16, 2025

Via Benzinga

Neumora (NMRA) Q2 Loss Improves 10% ↗

August 06, 2025

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 28, 2025

Via Benzinga

Boston Beer Posts Better-Than-Expected Earnings, Joins Scholastic, Deckers Outdoor, Saia And Other Big Stocks Moving Higher On Friday ↗

July 25, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 18, 2025

Via Benzinga

These stocks are moving in today's session ↗

July 09, 2025

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

June 09, 2025

The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 19, 2025

Via Benzinga

Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy' ↗

March 07, 2025

Johnson & Johnson discontinues aticaprant's Phase 3 trial but explores future options. Another depression drug Spravato sales hit $1.01 billion

Via Benzinga

Rivian Automotive, Cerence, Nu Skin Enterprises And Other Big Stocks Moving Higher On Friday ↗

January 03, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 02, 2025

Via Benzinga

Crude Oil Surges 2%; Tesla Shares Plummet ↗

January 02, 2025

Via Benzinga

Nasdaq Dips Over 100 Points; Unity Software Shares Jump ↗

January 02, 2025

Via Benzinga

Dow Surges Over 300 Points; US Initial Jobless Claims Decline ↗

January 02, 2025

Via Benzinga

Topics Stocks

Neumora Therapeutics Stock Crashes 83% After Depression Drug Flops ↗

January 02, 2025

The company said it plans to investigate a positive signal from female patients.

Via Investor's Business Daily

Neumora Therapeutics, XPeng And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

January 02, 2025

Via Benzinga

Neumora Therapeutics Depression Drug Fails In First Of Three Pivotal Phase 3 Trials ↗

January 02, 2025

Neumora's KOASTAL-1 study results show navacaprant missed key goals in major depressive disorder. Additional studies and updates are anticipated.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 18, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 02, 2024

Via Benzinga

This Cognex Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗

November 05, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 21, 2024

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.